Kolon ENP (KRX:138490)

Market Cap	242.82B
Revenue (ttm)	487.01B
Net Income (ttm)	41.99B
Shares Out	38.00M
EPS (ttm)	1,104.94
PE Ratio	5.78
Forward PE	6.80
Dividend	200.00 (3.01%)
Ex-Dividend Date	Dec 27, 2024

Volume	97,421
Average Volume	71,700
Open	6,640.00
Previous Close	6,640.00
Day's Range	6,350.00 - 6,640.00
52-Week Range	4,775.00 - 7,400.00
Beta	0.28
RSI	32.59
Earnings Date	Aug 7, 2025

About CTI BioPharma

Kolon ENP produces and sells engineering plastic products in South Korea and internationally. The company’s products include KOCETAL-POM, a polyacetal resin of a copolymer type; KOPA-PA6, a plastic material based on polyamide-6; KOPA-PA66, a thermoplastic resin; SPESIN-PBT, a thermal plastic resin; KOPEL-TPC-ET, a thermoplastic polyester elastomer; KOPPS polyphenylene sulfide resins; and KompoGTe long fiber reinforced thermoplastics and uni-directional tapes. Its products are used in lightweight automobiles, high-end home appliances, and electr...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1996
• Employees: 392
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 138490

Financial Performance

In 2024, Kolon ENP's revenue was 486.21 billion, an increase of 6.58% compared to the previous year's 456.20 billion. Earnings were 39.47 billion, an increase of 20.33%.